Qlight develops Quantum Dots - semiconductor nanocrystals that display unique optical and electrical properties. Qlight’s nanocrystals enable light conversion from UV and blue wavelengths to any other wavelength in the visible range.
Sol-Gel develops products which enable the entrapment of organic and bioorganic molecules in glass by using a room-temperature chemical process. The initial application deals with a new formulation for existing chemical and physical sunscreens.
Developed by award-winning industrial designers, the Ripple Maker works by combining patented 3D printer mechanics with Ink-Jet printing technologies using natural coffee extract, called Ripple Pods, to create the Ripples.
Tiltan Pharma’s proprietary anti-cancer platform is based on a combination of agents that target different, non-overlapping aspects of the angiogenic process. All of these agents are orally bio-available and FDA approved. The therapy cycle is a carefully timed and balanced in a patient-friendly treatment regimen that maximizes the synergistic effect of these agents and combines them into a singularly effective cancer treatment. The company’s platform technology enables an accelerated drug-discovery program.